Differential effects of depot medroxyprogesterone acetate administration on vaginal microbiome in Hispanic White and Black women
ABSTRACTThe use of depot medroxyprogesterone acetate (DMPA), a 3-monthly injectable hormonal contraceptive, is associated with an increased risk of HIV acquisition possibly through alteration of the vaginal microbiome. In this longitudinal interventional study, we investigated the impact of DMPA adm...
Main Authors: | Liying Yang, Yuhan Hao, Jiyuan Hu, Dervla Kelly, Huilin Li, Stuart Brown, Carley Tasker, Natalie E. Roche, Theresa L. Chang, Zhiheng Pei |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2019-01-01
|
Series: | Emerging Microbes and Infections |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/22221751.2018.1563458 |
Similar Items
-
Effect of depot-medroxyprogesterone acetate injections on serum immunoglobulins and complements level
by: Wahda B. Al-Youzbaki
Published: (2008-12-01) -
The effect of <i>Vigna unguiculata</i> on the estrogen receptor-α expression and the endometrial thickness in rats treated with depot medroxyprogesterone acetate (DMPA)
by: Rizki Fitrianingtyas, et al.
Published: (2023-12-01) -
A randomized crossover study to evaluate local tolerability following subcutaneous administration of a new depot medroxyprogesterone acetate contraceptive formulation
by: Vera Halpern, et al.
Published: (2023-01-01) -
Bone Mineral Density in Antiretroviral Therapy‐Naïve HIV‐1–Infected Young Adult ‐Women Using Depot Medroxyprogesterone Acetate or Nonhormonal Contraceptives in Uganda
by: Flavia Kiweewa Matovu, et al.
Published: (2021-02-01) -
Medroxyprogesterone Acetate Plus Metformin to Prevent Persistent Endometrial Hyperplasia
by: Vakkas Korkmaz, et al.
Published: (2013-08-01)